Blood thinners after stroke while on a blood thinner
Treatments studied
Part of Brain & nervous system, Heart & circulation clinical trials.
This trial tests whether switching to a different type of blood thinner is better than continuing the same type after a stroke. It aims to find the safest way to prevent another stroke in people with atrial fibrillation.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are over 18 years old.
- You have atrial fibrillation (an irregular heartbeat).
- You had a stroke within the last 14 days while taking a DOAC (a type of blood thinner).
- Your doctor thinks it is safe to start a blood thinner within 24 hours after joining the trial.
- You have not had bleeding in the brain before, and you are not on dialysis.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether taking a blood thinner after a stroke is safe and helpful for people who have atrial fibrillation (an irregular heartbeat) and have had a bleeding stroke in the past. It aims to prevent future strokes while managing the risk of another brain bleed.
This trial tests whether starting blood thinners soon after a procedure to remove a blood clot from the brain can safely prevent another stroke in people who have atrial fibrillation. Participation is for those who had a severe stroke, received the clot-removal procedure, and are medically stable afterward.
This study looks at people who had a stroke while taking blood thinners (anticoagulants) for an irregular heartbeat. It aims to learn more about these strokes and how to better prevent them in the future.
This trial compares two ways to manage blood-thinning medications after a successful atrial fibrillation ablation, specifically for people who also have a heart stent. It aims to find the safest and most effective strategy to prevent strokes and bleeding.
This trial tests a new medication to prevent strokes and blood clots in people with atrial fibrillation (an irregular heartbeat) who cannot safely take standard blood thinners. The drug works by blocking a different clotting factor, which may lower bleeding risks.
This study tests the safety of a new blood thinner for people with atrial fibrillation (AFib) who need long-term stroke prevention. If you qualify, the study will compare this medication to standard anticoagulation therapy.
Hear when a new Stroke (in Patients With Atrial Fibrillation) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.